Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
72.2 CHF | +0.84% | +0.84% | +41.85% |
Apr. 26 | Cosmo Pharmaceuticals N.V. Announces Executive Changes at the Upcoming Annual General Meeting on 24 May 2024 | CI |
Apr. 25 | Cosmo Pharmaceuticals Names New CEO, Chairman | MT |
Sales 2023 | 96.72M 104M 94.16M | Sales 2024 * | 262M 282M 255M | Capitalization | 1.19B 1.28B 1.16B |
---|---|---|---|---|---|
Net income 2023 | 1M 1.08M 973K | Net income 2024 * | 111M 119M 108M | EV / Sales 2023 | 8.6 x |
Net cash position 2023 | 48.44M 52.12M 47.15M | Net cash position 2024 * | 110M 119M 107M | EV / Sales 2024 * | 4.12 x |
P/E ratio 2023 |
771
x | P/E ratio 2024 * |
10.2
x | Employees | 319 |
Yield 2023 |
3.65% | Yield 2024 * |
2.83% | Free-Float | 44.49% |
Latest transcript on Cosmo Pharmaceuticals N.V.
1 day | +0.84% | ||
1 week | +0.84% | ||
Current month | -0.14% | ||
1 month | +5.71% | ||
3 months | +18.95% | ||
6 months | +97.54% | ||
Current year | +41.85% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 61 | 05-12-31 | |
Niall Donnelly
DFI | Director of Finance/CFO | 52 | 16-05-31 |
Chief Tech/Sci/R&D Officer | 54 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
David W Maris
BRD | Director/Board Member | 57 | 21-05-27 |
Founder | 69 | 96-12-31 | |
Director/Board Member | 64 | 05-12-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 10 M€ | -3.35% | - | |
0.00% | 773 M€ | -.--% | - | |
0.00% | 34 M€ | +2.67% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-03 | 72.2 | +0.84% | 11,784 |
24-05-02 | 71.6 | -0.97% | 10,802 |
24-04-30 | 72.3 | +0.28% | 12,031 |
24-04-29 | 72.1 | +0.70% | 5,862 |
24-04-26 | 71.6 | -0.69% | 4,709 |
Delayed Quote Swiss Exchange, May 03, 2024 at 11:30 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+41.85% | 1.28B | |
+21.85% | 546B | |
-4.77% | 359B | |
+16.97% | 323B | |
+5.69% | 290B | |
+13.68% | 234B | |
+3.65% | 198B | |
-11.12% | 194B | |
+8.08% | 167B | |
-3.40% | 157B |
- Stock Market
- Equities
- COPN Stock